Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 11, 1997, Pages 1248-1254

  de Vries, J I P ^a   Dekker, G A ^a   Huijgensb, P C ^a   Jakobs, C ^a   Blomberg, B M E ^a   van Geijn, H P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTITHROMBIN III DEFICIENCY; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DEATH; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; RISK FACTOR; SOLUTIO PLACENTAE; THROMBOSIS;

ABRUPTIO PLACENTAE; ANTIBODIES, ANTICARDIOLIPIN; BLOOD COAGULATION DISORDERS; FEMALE; FETAL DEATH; GESTATIONAL AGE; HOMOCYSTEINE; HUMANS; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTEIN S DEFICIENCY; RISK FACTORS;

EID: 0030690585     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb10970.x     Document Type: Article

References (30)

1. Keregard M, Gennser G. Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol 1986; 67: 523–528.
2. Kraus T, Rath W, Kuhn W. Mutterliche und kindliche Morbiditat und Mortalitat bei der vorzeitigen Placentalosung-eine retrospektive Analyse. Geburtshilfe Frauenheilkd 1993; 53: 1944–1997.
3. Beischer NA, De Garis CN. Unexplained intrauterine death near term. Aust N Z J Obstet Gynaecol 1986; 26: 99–101.
4. Lyon AJ, Clarkson P, Jeffrey I, West GA. Effect of ethnic origin of mother on fetal outcome. Arch Dis Child 1994; 70:40–43.
5. Kloosterman GJ. On intrauterine growth: The significance of prenatal care. IntJ Gynaecol Obstet 1970; 8: 895–912.
6. Fikree FF, Berendes HW, Midhet F, D’Souza RM, Hussain R. Risk factors for intrauterine growth retardation: results of a community- based study from Karachi. JPMA J Pak Med Assoc 1994; 44: 30–34.
7. Visser GHA, Huisman A, Saathof PW, Sinnige HA. Early fetal growth retardation obstetric background and recurrence rate. Obstet Gynecol 1986; 67: 40–43.
8. Dekker GA, de Vries JIP, Doelitzch PM, Huijgens PC, Von Blomberg BME, Jakobs C et al. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042–1048.
9. Goddijn-Wessel TAW, Wouters MGAJ, van de Molen EF et al. Hyperhomocysteinaemia: a risk factor for placental abruption or infaction. Eur J Obstet Gynecol Reprod Biol 1996; 66: 23–29.
10. Preston FE, Rosendaal FR, Walker ID et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348:913–916.
11. van den Berg M, Franken DC, Boers GHJ, Blom HJ, Jakobs C, Stehouwer CDA, Rauwerda JA. Combined Vitamin B6 plus Folic Acid Therapy in Young Patients with arteriosclerosis and Hyperhomocysteinaemia. J Vase Surg 1994; 20:933–940.
12. Daly L, Meleady R, Graham I. Fasting or post-methionine load homocysteine: which should be measured in relation to vascular risk Irish J Med Science 1995; 164:6.
13. Wouters MGAJ, Moorrees MThEC, van der Mooren MJ, Blom HJ, Boers GHJ, Schellekens LA et al. Plasmahomocysteine and meno- pausal status. Eur J Clin Invest 1995; 25: 801–805.
14. Boers GHJ, van den Berg M, Franken DG. Treatment of mild hyper- homocysteinaemia. In: van den Berg M. Hyperhomocysteinaemia and Arterial Disease: General Aspects and Effects of Treatment. Enschede: Febodruk BV, 1995; 69–79.
15. Dahlback H, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor antico- agulant response to activated protein C: prediction of a cofactor to activated protein C.ProcNatlAcadSci USA 1993; 90: 1004–1008.
16. Roster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503–1506.
17. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contracep- tive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–1457.
18. Triplett DA, Brandt J. Laboratory identification of lupus anticoagu- lant. Br J Haematol 1989; 73: 139–142.
19. Harris EN. The second international anti-cardiolipin standardization workshop/the Kingston Antiphospholipid antibody study (KAPS) group. Am J Clin Path 1990; 94: 476–484.
20. Mudd SH, Levy HL, Skovby F. Disorders of transsulraration. In: Scriver CR, Beaudet AL, Sly WS et al.editors. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill 1989; 693–734.
21. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jacobs C et al. Coexistence of heriditary homocysteinuria and factor V Leiden-effect on thrombosis. N Engl J Med 1996; 334:763–768.
22. van den Berg M, Stehouer CDA, Bierdrager E, Rauwerda JA. Plasma homocysteine and severity of atherosclerosis in young patients with lower extremity atherosclerotic disease. Aterioscler Throm Vase Biol 1996; 16: 165–171.
23. Steegers-Theunissen RPM, Boers GHJ, Trijbels JMF et al. Maternal Hyperhomocysteinemia: a risk factor for neural tube defects Metabolism 1994; 43: 1475–1480.
24. Wouters MGAJ, Boers GHJ, Blom HJ et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. FertilSteril 1993; 60: 820–825.
25. Burke G, Robinson K, Refsum H, Stuart B, Drumm J, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. New Engl J Med 1992; 326: 69–70.
26. van den Berg M, Stehouer CDA, Boers GHJ, Rauwerda JA, Kluft C. Arterial disease in hyperhomocysteinaemia and the effect of treatment: a Pilot study. Fibrinolysis 1994; 8 Suppl 2:88–90.
27. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Baltimore: Williams and Williams, 1994: 75–387.
28. Koster T Rosendaal FR, de Ronde H, Bria E, Van de Brouke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 42: 1503–1506.
29. Tail RC, Walker ID, Islam SIAM et al. Protein S deficiency in healthy blood donors [abstract]. Br J ffaematology 1994; 86 Suppl: 118.
30. Pattison NS, Birdsall MA, Chamley LW, Lubbe WF. Recurrent fetal loss and the antiphospholipid syndrome. Recent Adv Obstet Gynecol 1994; 18: 23–50.